Schuster F R, Laws H-J
Hämatologisch/Onkologische Abteilung, Dr. von Haunersches Kinderspital, Ludwig-Maximilians-Universität München.
Klin Padiatr. 2005 Nov;217 Suppl 1:S143-9. doi: 10.1055/s-2005-872508.
Infectious complications are a major cause of morbidity and mortality in pediatric and adult patients undergoing hematopoietic stem cell transplantation. The incidence and the severity code of infections depend on the function of the host's immune system. This function is strongly correlated to the application of immune suppressive therapy and the speed of immune reconstitution after stem cell transplantation (SCT). The immune reconstitution can be divided into an early, intermediate and a late phase. This article describes the risk of infections during the different phases of immune reconstitution after stem cell transplantation in children. The basic differences between conventional treated oncologic, autologous and allogenic transplanted children will be presented. Beside the risk in the phase of aplasia there should be pointed out that long term immune deficiency is a strong factor for developing a severe infection after SCT.
感染并发症是接受造血干细胞移植的儿科和成年患者发病和死亡的主要原因。感染的发生率和严重程度取决于宿主免疫系统的功能。该功能与免疫抑制治疗的应用以及干细胞移植(SCT)后免疫重建的速度密切相关。免疫重建可分为早期、中期和晚期。本文描述了儿童干细胞移植后免疫重建不同阶段的感染风险。还将介绍传统治疗的肿瘤患儿、自体移植患儿和异体移植患儿之间的基本差异。除了再生障碍期的风险外,还应指出长期免疫缺陷是SCT后发生严重感染的一个重要因素。